Gestonorone caproate (BioDeep_00000717808)

   


代谢物信息卡片


Gestonorone Capronate

化学式: C26H38O4 (414.2769948)
中文名称: 己酸己酮
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C(=O)C
InChI: InChI=1S/C26H38O4/c1-4-5-6-7-24(29)30-26(17(2)27)15-13-23-22-10-8-18-16-19(28)9-11-20(18)21(22)12-14-25(23,26)3/h16,20-23H,4-15H2,1-3H3/t20-,21+,22+,23-,25-,26-/m0/s1

描述信息

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

同义名列表

2 个代谢物同义名

Gestonorone Capronate; Gestonorone caproate



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • H Iguchi, T Ikeuchi, Y Kai, H Yoshida. [Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism]. Hinyokika kiyo. Acta urologica Japonica. 1994 Mar; 40(3):215-9. doi: NULL. [PMID: 7513937]
  • F Di Silverio, G D'Eramo, G P Flammia, M Buscarini, E Frascaro, M Mariani, A Sciarra. [Pharmacological combinations in the treatment of benign prostatic hypertrophy]. Journal d'urologie. 1993; 99(6):316-20. doi: ". [PMID: 7516378]
  • A Adler, G Gillon, H Lurie, J Shaham, D Loven, Y Shachter, A Shani, C Servadio, J A Stein. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects. Journal of biological response modifiers. 1987 Dec; 6(6):610-24. doi: NULL. [PMID: 3330126]
  • G A Turner, R D Ellis, D Guthrie, A L Latner, W M Ross, A W Skillen. Cyclic GMP in urine to monitor the response to ovarian cancer to therapy. British journal of obstetrics and gynaecology. 1982 Sep; 89(9):760-4. doi: 10.1111/j.1471-0528.1982.tb05105.x. [PMID: 6288064]
  • A Schoenenberger, D Hauri. [Conservative treatment of benign prostatic hyperplasia (author's transl)]. Therapeutische Umschau. Revue therapeutique. 1982 Apr; 39(4):260-7. doi: ". [PMID: 6179177]
  • R Pavelka, R Schmid, W H Schneider, J Spona. [Hormonal and functional parameters in hyperprolactinaemia (author's transl)]. Wiener klinische Wochenschrift. 1979 Dec; 91(23):793-8. doi: NULL. [PMID: 538934]
  • U Tunn, T Senge. [Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry]. Zeitschrift fur Urologie und Nephrologie. 1978 Aug; 71(8):521-8. doi: NULL. [PMID: 83057]
  • R Lindsay, D M Hart, D Purdie, M M Ferguson, A S Clark, A Kraszewski. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clinical science and molecular medicine. 1978 Feb; 54(2):193-5. doi: 10.1042/cs0540193. [PMID: 340117]
  • S Sander, R Nissen-Meyer, A Aakvaag. On gestagen treatment of advanced prostatic carcinoma. Scandinavian journal of urology and nephrology. 1978; 12(2):119-21. doi: 10.3109/00365597809179977. [PMID: 694436]
  • L Giuliani, D Pescatore, C Giberti. [Hormone therapy in renal adenocarcinoma]. Minerva chirurgica. 1977 Dec; 32(23-24):1463-5. doi: NULL. [PMID: 600435]
  • D Meiraz, Y Margolin, A Lev-Ran, J Lazebnik. Treatment of benign prostatic hyperplasia with hydroxyprogesterone-caproate: placebo-controlled study. Urology. 1977 Feb; 9(2):144-8. doi: 10.1016/0090-4295(77)90184-4. [PMID: 65818]
  • E Palanca, W Juco. Conservative treatment of benign prostatic hyperplasia. Current medical research and opinion. 1977; 4(7):513-20. doi: 10.1185/03007997709109342. [PMID: 66118]
  • F Orestano, J E Altwein. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate. British journal of urology. 1976 Dec; 48(6):485-91. doi: 10.1111/j.1464-410x.1976.tb06687.x. [PMID: 64267]
  • M Marberger, J E Altwein, F Orestano. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study. Investigative urology. 1976 Jan; 13(4):302-6. doi: NULL. [PMID: 1245393]
  • W Baumann, G Horn, G Unger. [Gestagen treatment in adenoma of the bladder neck. I. Roentgenological and isotope nephrographic studies]. Zeitschrift fur Urologie und Nephrologie. 1975 May; 68(5):367-72. doi: NULL. [PMID: 1229767]
  • L Carlborg. Effect of norhydroxyprogesterone caproate on cervical sperm penetration and secretion of ovarian steroids in the human female. Upsala journal of medical sciences. 1973 Jul; 78(3):189-90. doi: 10.3109/03009737309178626. [PMID: 4797435]
  • N Subbiah, J Mortensen. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat). The Australian and New Zealand journal of surgery. 1973 Feb; 42(3):304-7. doi: 10.1111/j.1445-2197.1973.tb06805.x. [PMID: 4129814]
  • W Schneider, K Voigt. [Basic hormonal situation in women with secondary amenorrhea with particular consideration of rhythmic reactions after a single dose of progestogen (author's transl)]. Acta Europaea fertilitatis. 1972 Mar; 3(1):59-69. doi: NULL. [PMID: 4679555]
  • H Ippen, D Aust, G Goerz. [Experimental porphyria. 3. Effects of steroids on latent hexachlorobenzene-porphyria of rats]. Archiv fur dermatologische Forschung. 1972; 245(4):305-17. doi: NULL. [PMID: 4641683]